DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Levothroid (Levothyroxine) - Overdose - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Overdose (5)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Levothroid (Levothyroxine) where reactions include overdose. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Levothroid side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-22

Patient: female, weighing 65.4 kg (143.9 pounds)

Reactions: Blood Pressure Increased, Dyspnoea, Labile Hypertension, Drug Ineffective, Urinary Incontinence, Blood Potassium Increased, Headache, Hypertensive Crisis, Overdose, Bronchitis, Cough, Atrioventricular Block First Degree

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Labetalol
    Dosage: 1 df, qid

Levothroid
    Dosage: 600 ug, unk
    Administration route: Oral

Levothroid
    Dosage: 300 ug, unk
    Administration route: Oral

Gilenya
    Dosage: 0.5 mg, qd
    Administration route: Oral
    Indication: Multiple Sclerosis
    Start date: 2011-06-06
    End date: 2011-11-04

Labetalol
    Dosage: 1 df, q6h
    Administration route: Oral

Catapres
    Dosage: 0.1 mg, tid (prn)
    Administration route: Oral

Zestril
    Dosage: 10 mg, bid

Labetalol
    Dosage: 900 mg, once/single
    Administration route: Oral

Lopressor
    Dosage: 50 mg, tid
    Administration route: Oral

Catapres
    Dosage: 0.1 mg, tid (prn)
    Administration route: Oral

Cardizem LA
    Dosage: unk ukn, unk
    Indication: Coronary Artery Disease

Other drugs received by patient: Synthroid; Aldactone; Amitiza; Clonidine; Aldactone; Prozac; Prilosec; Vitamin D; Valium; Dyazide; Valium



Possible Levothroid side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-22

Patient: female, weighing 65.4 kg (143.9 pounds)

Reactions: Blood Pressure Increased, Dyspnoea, Labile Hypertension, Drug Ineffective, Urinary Incontinence, Blood Potassium Increased, Headache, Hypertensive Crisis, Overdose, Bronchitis, Cough, Atrioventricular Block First Degree

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Levothroid
    Dosage: 300 ug, unk
    Administration route: Oral

Levothroid
    Dosage: 600 ug, unk
    Administration route: Oral

Catapres
    Dosage: 0.1 mg, tid (prn)
    Administration route: Oral

Labetalol HCL
    Dosage: 1 df, q6h
    Administration route: Oral

Catapres
    Dosage: 0.1 mg, tid (prn)
    Administration route: Oral

Labetalol HCL
    Dosage: 1 df, qid

Gilenya
    Dosage: 0.5 mg, qd
    Administration route: Oral
    Indication: Multiple Sclerosis
    Start date: 2011-06-06
    End date: 2011-11-04

Lopressor
    Dosage: 50 mg, tid
    Administration route: Oral

Cardizem LA
    Dosage: unk ukn, unk
    Indication: Coronary Artery Disease

Labetalol HCL
    Dosage: 900 mg, once/single
    Administration route: Oral

Zestril
    Dosage: 10 mg, bid

Other drugs received by patient: Prozac; Vitamin D; Synthroid; Aldactone; Valium; Valium; Prilosec; Clonidine; Aldactone; Dyazide; Amitiza



Possible Levothroid side effects in female

Reported by a physician from United States on 2012-01-09

Patient: female, weighing 65.4 kg (143.9 pounds)

Reactions: Blood Pressure Increased, Dyspnoea, Labile Hypertension, Drug Ineffective, Urinary Incontinence, Blood Potassium Increased, Headache, Hypertensive Crisis, Overdose, Bronchitis, Atrioventricular Block First Degree, Cough

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Lopressor
    Dosage: 50 mg, tid
    Administration route: Oral

Gilenya
    Dosage: 0.5 mg, qd
    Administration route: Oral
    Indication: Multiple Sclerosis
    Start date: 2001-06-06
    End date: 2011-11-04

Levothroid
    Dosage: 300 ug, unk
    Administration route: Oral

Labetalol HCL
    Dosage: 900 mg, once/single
    Administration route: Oral

Labetalol HCL
    Dosage: 1 df, qid

Gilenya
    Indication: Demyelination

Labetalol HCL
    Dosage: 1 df, q6h
    Administration route: Oral

Cardizem LA
    Dosage: unk ukn, unk
    Indication: Coronary Artery Disease

Levothroid
    Dosage: 600 ug, unk
    Administration route: Oral

Catapres
    Dosage: 0.1 mg, tid (prn)
    Administration route: Oral

Zestril
    Dosage: 10 mg, bid

Catapres
    Dosage: 0.1 mg, tid (prn)
    Administration route: Oral

Other drugs received by patient: Amitiza; Prozac; Dyazide; Clonidine; Vitamin D; Aldactone; Aldactone; Valium; Synthroid; Valium; Prilosec



Possible Levothroid side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-09

Patient: female, weighing 65.4 kg (143.9 pounds)

Reactions: Blood Pressure Increased, Dyspnoea, Drug Ineffective, Labile Hypertension, Urinary Incontinence, Blood Potassium Increased, Headache, Hypertensive Crisis, Overdose, Bronchitis, Atrioventricular Block First Degree, Cough

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Labetalol HCL
    Dosage: 1 df, qid

Lopressor
    Dosage: 50 mg, tid
    Administration route: Oral

Labetalol HCL
    Dosage: 1 df, q6h
    Administration route: Oral

Catapres
    Dosage: 0.1 mg, tid (prn)
    Administration route: Oral

Zestril
    Dosage: 10 mg, bid

Levothroid
    Dosage: 300 ug, unk
    Administration route: Oral

Cardizem LA
    Dosage: unk ukn, unk
    Indication: Coronary Artery Disease

Gilenya
    Dosage: 0.5 mg, qd
    Administration route: Oral
    Indication: Multiple Sclerosis
    Start date: 2001-06-06
    End date: 2011-11-04

Labetalol HCL
    Dosage: 900 mg, once/single
    Administration route: Oral

Catapres
    Dosage: 0.1 mg, tid (prn)
    Administration route: Oral

Gilenya
    Indication: Demyelination

Levothroid
    Dosage: 600 ug, unk
    Administration route: Oral

Other drugs received by patient: Synthroid; Valium; Prilosec; Prozac; Aldactone; Amitiza; Valium; Aldactone; Dyazide; Clonidine; Vitamin D



Possible Levothroid side effects in female

Reported by a physician from United States on 2012-01-09

Patient: female, weighing 65.4 kg (143.9 pounds)

Reactions: Blood Pressure Increased, Dyspnoea, Labile Hypertension, Drug Ineffective, Urinary Incontinence, Blood Potassium Increased, Headache, Hypertensive Crisis, Overdose, Bronchitis, Atrioventricular Block First Degree, Cough

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Lopressor
    Dosage: 50 mg, tid
    Administration route: Oral

Labetalol HCL
    Dosage: 1 df, q6h
    Administration route: Oral

Gilenya
    Dosage: 0.5 mg, qd
    Administration route: Oral
    Indication: Multiple Sclerosis
    Start date: 2001-06-06
    End date: 2011-11-04

Gilenya
    Indication: Demyelination

Levothroid
    Dosage: 600 ug, unk
    Administration route: Oral

Levothroid
    Dosage: 300 ug, unk
    Administration route: Oral

Labetalol HCL
    Dosage: 900 mg, once/single
    Administration route: Oral

Labetalol HCL
    Dosage: 1 df, qid

Cardizem LA
    Dosage: unk ukn, unk
    Indication: Coronary Artery Disease

Clonidine
    Dosage: 0.1 mg, tid (prn)
    Administration route: Oral

Clonidine
    Dosage: 0.1 mg, tid (prn)
    Administration route: Oral

Zestril
    Dosage: 10 mg, bid

Other drugs received by patient: Prozac; Amitiza; Synthroid; Valium; Dyazide; Aldactone; Valium; Prilosec; Clonidine; Vitamin D; Aldactone

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017